2023

• Allen, N., Martin, A., Snaidr, V., Eggins, R., Chong, A., Fernandez Penas, P., Gin, D., Sidhu, S., Paddon, V., Banney, L., Lim, A., McKenzie, C., Scolyer, R., Dhillon, H., Vardy, J., Chadban, S., Bowen, D., Chen, A., Damian, D., et al (2023). Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients. New England Journal of Medicine, 388(9), 804-812. [More Information]

2020

• Malesu, R., Martin, A., Lyons, J., Scolyer, R., Chen, A., McKenzie, C., Madore, J., Halliday, G., Damian, D. (2020). Nicotinamide for skin cancer chemoprevention: Effects of nicotinamide on melanoma: In vitro and in vivo. Photochemical & Photobiological Sciences, 19(2), 171-179. [More Information]

2019

• Minocha, R., Martin, A., Chen, A., Scolyer, R., Lyons, J., McKenzie, C., Madore, J., Halliday, G., Damian, D. (2019). A reduction in inflammatory macrophages may contribute to skin cancer chemoprevention by nicotinamide. Journal of Investigative Dermatology, 139(2), 467-469. [More Information]
• Martin, A., Dhillon, H., Vardy, J., Dalziell, R., Choy, B., Fernandez Penas, P., Dixon, A., Renton, C., St George, G., Chinniah, N., Halliday, G., Damian, D., Chen, A. (2019). Neurocognitive Function and Quality of Life Outcomes in the ONTRAC Study for Skin Cancer Chemoprevention by Nicotinamide. Geriatrics, 4(1), 1-6. [More Information]

2017

• Damian, D., Martin, A., Scolyer, R., Chen, A., Halliday, G. (2017). Reply to 'A phase II randomized controlled trial of nicotinamide for skin cancer chemoprevention in renal transplant recipients': reply from the authors. British Journal of Dermatology, 176(2), 552-553. [More Information]

2016

• Chen, A., Martin, A., Dalziell, R., McKenzie, C., Lowe, P., Eris, J., Scolyer, R., Dhillon, H., Vardy, J., Bielski, V., Halliday, G., Damian, D. (2016). A Phase II Randomised Controlled Trial of Nicotinamide for Skin Cancer Chemoprevention in Renal Transplant Recipients. British Journal of Dermatology, 175(5), 1073-1075. [More Information]
• McKenzie, C., Chen, A., Choy, B., Fernandez Penas, P., Damian, D., Scolyer, R. (2016). Classification of high risk basal cell carcinoma subtypes: experience of the ONTRAC study with proposed definitions and guidelines for pathological reporting. Pathology, 48(5), 395-397. [More Information]
• Chen, A., Martin, A., Dalziell, R., Halliday, G., Damian, D. (2016). Oral nicotinamide reduces transepidermal water loss: a randomised controlled trial. British Journal of Dermatology, 175(6), 1363-1365. [More Information]
• Chen, A., Martin, A., Damian, D. (2016). The authors reply: Nicotinamide for Skin-Cancer Chemoprevention. New England Journal of Medicine, 374(8), 789-790. [More Information]

2015

• Chen, A., Martin, A., Choy, B., Fernandez Penas, P., Dalziell, R., McKenzie, C., Scolyer, R., Dhillon, H., Vardy, J., Kricker, A., St George, G., Chinniah, N., Halliday, G., Damian, D. (2015). A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. New England Journal of Medicine, 373(17), 1618-1626. [More Information]
• Rennie, G., Chen, A., Dhillon, H., Vardy, J., Damian, D. (2015). Nicotinamide and neurocognitive function. Nutritional Neuroscience, 18(5), 193-200. [More Information]

2014

• Chen, A., Damian, D. (2014). Nicotinamide and the skin. Australasian Journal of Dermatology, 55(3), 169-175. [More Information]
• Chen, A., Damian, D., Halliday, G. (2014). Oral and systemic photoprotection. Photodermatology, Photoimmunology & Photomedicine, 30(2-3), 102-111. [More Information]

2013

• Chen, A., Halliday, G., Damian, D. (2013). Non-melanoma skin cancer: carcinogenesis and chemoprevention. Pathology, 45(3), 331-341. [More Information]